Fonds Vives II (University of Louvain, UCL)
Description
Fonds Vives II (University of Louvain, UCL)
Investor Profile
Fonds Vives II (University of Louvain, UCL) has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in Belgium, United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (40%)
- Series A (40%)
- Seed (20%)
Country Focus
- Belgium (60%)
- United States (40%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Health Diagnostics
- Home Health Care
- Lifestyle
- Medical Device
- Wellness
- Biopharma
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Fonds Vives II (University of Louvain, UCL) frequently co-invest with?
Which angels does Fonds Vives II (University of Louvain, UCL) often collaborate with?
What are some of recent deals done by Fonds Vives II (University of Louvain, UCL)?
Find More Investors Like Fonds Vives II (University of Louvain, UCL)
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









